We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spire Healthcare Group Plc | LSE:SPI | London | Ordinary Share | GB00BNLPYF73 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.50 | 1.02% | 248.00 | 247.50 | 248.00 | 248.00 | 247.00 | 247.00 | 225,483 | 16:29:33 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 1.36B | 27.3M | 0.0676 | 36.69 | 1B |
TIDMSPI
RNS Number : 3329D
Spire Healthcare Group PLC
08 October 2018
8 October 2018
Spire Healthcare Group plc
Grant of 2018 Long Term Incentive Plan awards
Spire Healthcare Group plc (the "Company") announces that, on 8 October 2018, a performance share award (the "Award") was granted over the Company's ordinary shares in the form of nil cost options to the following Executive Director in the Company, under the rules of the Spire Healthcare Group plc Long Term Incentive Plan.
Name Maximum number of shares under Award Jitesh Sodha 415,381
The number of shares set out above is the maximum number which may vest under the Award following the cessation of the performance period. The actual number of shares which vest will depend on the extent to which the following performance conditions have been satisfied.
The performance conditions applicable to the Award will be based as follows:
-- 35% on relative total shareholder return (TSR) performance; -- 35% on adjusted earnings per share (EPS) performance; and -- 30% on two Operational Excellence measures.
Furher details of these performance conditions were disclosed in the 2017 Directors' Remuneration Report which was published in April.
The share price used to determine the number of shares under the Award was GBP1.4264 being the average of the middle market quotation over the last five dealing days ending on 5 October 2018.
The transaction place is London.
Name of contact and telephone number for queries:
Philip Davies 020 7427 9092
Deputy Company Secretary
The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
a) Name Jitesh Sodha ------------------------------------- -------------------------------------------------- 2 Reason for the notification ----------------------------------------------------------------------------------------- a) Position/status Chief Financial Officer and Executive Director ------------------------------------- -------------------------------------------------- b) Initial notification Initial notification /Amendment ------------------------------------- -------------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ----------------------------------------------------------------------------------------- a) Name Spire Healthcare Group plc ------------------------------------- -------------------------------------------------- b) LEI 213800IBJPW3SE2RA350 ------------------------------------- -------------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ----------------------------------------------------------------------------------------- a) Description of Ordinary shares of 1 pence each the financial instrument, type GB00BNLPYF73 of instrument Identification code ------------------------------------- -------------------------------------------------- b) Nature of the Grant of performance share awards under transaction the Company's Long Term Incentive Plan ------------------------------------- -------------------------------------------------- c) Price(s) and volume(s) Price(s) Volume(s) ------------------------------------- ----------------------- ------------------------- Nil 415,381 ------------------------------------------------------------------ ------------------------- d) Aggregated information As above - Aggregated volume - Price ------------------------------------- -------------------------------------------------- e) Date of the transaction 2018-10-08 ------------------------------------- -------------------------------------------------- f) Place of the transaction XLON ------------------------------------- --------------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHBSBDGXUGBGII
(END) Dow Jones Newswires
October 08, 2018 10:54 ET (14:54 GMT)
1 Year Spire Healthcare Chart |
1 Month Spire Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions